
In this Q&A, Jesús Corral Jaime, MD, discusses real-world CEMI-LUNG data on cemiplimab in advanced NSCLC presented at the ESMO 2026 Congress.
Implementation of OCM does not have to be a burden. Dr. Gor explains the implementation of OCM, potential cost savings and utilization with non-oncology patients.


